Market Place
Sourcing Support
Eckert & Ziegler Gets Approval for GalliaPharm in Japan
19 Sep 2025 //
PHARMAWEB
6 Pharma Layoffs Could Eliminate Over 39,000 Jobs
18 Sep 2025 //
BIOSPACE
India Revokes Patent of Novartis` Blockbuster Cardiac Drug
16 Sep 2025 //
ECONOMICTIMES
FDA Issues Over 100 Warnings in Ad Crackdown
16 Sep 2025 //
RAPS
Novartis Signs up to $5.7 B licensing deal with Monte Rosa
15 Sep 2025 //
REUTERS
Novartis Falls in Another IRA Price Negotiation Loss for Pharma
12 Sep 2025 //
FIERCE PHARMA
Novartis to Acquire Tourmaline Bio for $1.4 Billion
09 Sep 2025 //
REUTERS
NRG Secures £50M Series B Funding for Parkinson`s Research
08 Sep 2025 //
GLOBENEWSWIRE
Novartis Signs up To $5.2 B Deal with China`s Biotech Argo
04 Sep 2025 //
REUTERS
Arrowhead, Novartis in Up to $2B Deal for Neuromuscular Therapy
03 Sep 2025 //
REUTERS
Novartis Plans 58 Layoffs in N.J.
02 Sep 2025 //
FIERCE PHARMA
Gateway to Growth: Innovation and Opportunity at the 8th CIIE
01 Sep 2025 //
BUSINESSWIRE
Novartis, BioArctic Partner To Penetrate the Blood-Brain Barrier
29 Aug 2025 //
BIOSPACE
BioArctic: Interim Report for the period April - June 2025
28 Aug 2025 //
PR NEWSWIRE
Lilly Answers Novartis Breast Cancer Rivalry with Survival Win
27 Aug 2025 //
FIERCE PHARMA
Novartis pens BioArctic neuro pact worth $30M upfront
27 Aug 2025 //
FIERCE BIOTECH
Novartis, BioArctic Partner on BrainTransporter for Neurology
26 Aug 2025 //
EXPRESSPHARMA
Novartis ESC Data Showcases Cardiovascular Portfolio Strength
18 Aug 2025 //
GLOBENEWSWIRE
Novartis Scores Double Phase 3 Win in Sjögren`s Syndrome
12 Aug 2025 //
FIERCE BIOTECH
Novartis Weighs Deal for Biotech Avidity Biosciences
09 Aug 2025 //
REUTERS
Novartis Hunts New Assets, Rumored Takeover of RNA Specialist
07 Aug 2025 //
BIOSPACE
FDA Approves Novartis` Leqvio (Inclisiran) for First-Line Use
31 Jul 2025 //
PR NEWSWIRE
Novartis India Reports Rs. 27.62 Cr Net Profit in Q1 FY26
30 Jul 2025 //
INDPHARMAPOST
Novartis Drops up to $1B+ for Drug Discovery Deal With Matchpoint
26 Jul 2025 //
GLOBENEWSWIRE
Analysis Group Explores HEOR Use in Rare Disease CGTs
22 Jul 2025 //
PR NEWSWIRE
Novartis Speeds up Us Manufacturing of Key Drugs as Tariffs
18 Jul 2025 //
BIOSPACE
Novartis` Pluvicto Picks up Speed, Delivers Another Trial Win
17 Jul 2025 //
FIERCE PHARMA
Novartis boosts FY 2025 core income outlook on robust Q2 sales
17 Jul 2025 //
GLOBENEWSWIRE
Novartis Names Mukul Mehta CFO as Harry Kirsch Retires
17 Jul 2025 //
GLOBENEWSWIRE
Novartis Loses Bid to Block Us Entresto Generic Through 2026
14 Jul 2025 //
REUTERS
US Entresto Generic Unblocked as Novartis Loses Bid till 2026
11 Jul 2025 //
REUTERS
Novartis inks $175M option deal for Sironax’s blood-brain barrier
10 Jul 2025 //
PR NEWSWIRE
Novartis` Malaria Drug for Babies Gets First Global Approval
08 Jul 2025 //
FIERCE PHARMA
Novartis gets Approval for First malaria drug for babies
08 Jul 2025 //
REUTERS
Novartis Drug Cosentyx Fails Late-Stage Trial for Artery Disease
05 Jul 2025 //
REUTERS
Novartis Pens ProFound Pact for Cardiovascular Disease Targets
27 Jun 2025 //
FIERCE BIOTECH
Novartis completes acquisition of Regulus Therapeutics
25 Jun 2025 //
GLOBENEWSWIRE
Amneal, Kashiv Report Positive Data for Xolair Biosimilar
25 Jun 2025 //
GLOBENEWSWIRE
Novartis HSR waiting period for Regulus Therapeutics offer ends
23 Jun 2025 //
GLOBENEWSWIRE
Biogen, BMS and Novartis bag spots on Cannes Lions shortlists
16 Jun 2025 //
FIERCE PHARMA
Novartis Fabhalta® improves hemoglobin in new PNH patients
12 Jun 2025 //
GLOBENEWSWIRE
Novartis Asks Court for Swift Decision in Entresto Patent Case
07 Jun 2025 //
FIERCE PHARMA
Novartis` Pluvicto to Slow Prostate Cancer in Earlier Setting
03 Jun 2025 //
REUTERS
Novartis Pluvicto Shows rPFS Benefit In PSMA+ Prostate Cancer
02 Jun 2025 //
GLOBENEWSWIRE
Novartis Kisqali Cut Recurrence Risk in Young Early Breast Cancer
01 Jun 2025 //
GLOBENEWSWIRE
Novartis expands collaboration with Shanghai Pharma in China
27 May 2025 //
FIERCE PHARMA
5 People Accused of Insider Trading Tied to Novartis Buy
27 May 2025 //
FIERCE BIOTECH
Novartis starts tender offer for Regulus Therapeutics
27 May 2025 //
GLOBENEWSWIRE
Apotex Launches Generic Tasigna Capsules in Us with Exclusivity
27 May 2025 //
PR NEWSWIRE
Novartis Offers Payment Plan for High-Cost Heart Medicine
27 May 2025 //
ECONOMICTIMES
Novartis data at ASCO and EHA highlights Momentum of Portfolio
15 May 2025 //
GLOBENEWSWIRE
Abu Dhabi, Novartis Ink Deal for Disease Prevention
14 May 2025 //
BIOSPECTRUM
Erasca looks to partner off late-stage melanoma asset
14 May 2025 //
FIERCE BIOTECH
Novartis to keep making malaria drugs if orders dry up amid cuts
12 May 2025 //
REUTERS
PTC and Novartis’ Huntington`s data fail to convince investors
07 May 2025 //
FIERCE BIOTECH
Incyte, Novartis reach settlement in Jakafi royalty dispute
06 May 2025 //
FIERCE PHARMA
BioNTech says Novartis executive Zapata to become CFO
05 May 2025 //
REUTERS
Novartis to buy Regulus in up to $1.7 Billion deal
01 May 2025 //
REUTERS
Novartis axes osteoarthritis asset and radioligand therapy
29 Apr 2025 //
FIERCE BIOTECH
Novartis builds momentum with new drug launches
29 Apr 2025 //
FIERCE PHARMA
